Stay updated on NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial page.

Latest updates to the NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA notice about NIH’s terminology transition appears above the 403 Forbidden message, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedA 403 Forbidden error is displayed on the page, indicating the study record is temporarily inaccessible and the page content cannot be loaded.SummaryDifference18%

- Check46 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0 on the page. This indicates a refreshed revision of the page content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a small, behind-the-scenes update to the page version without affecting the study details.SummaryDifference0.0%

- Check67 days agoChange DetectedThe study details now include a funding disclosure indicating NIH support in 2019. This provides transparency about the source of support for the NuTide:121 trial.SummaryDifference0.0%

Stay in the know with updates to NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial page.